RESMED (RME MU) stock market data APIs
€230.3937
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
RESMED Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for RME.MU.
Prev. Close
230.3937
Open
230.3937
High
230.3937
Low
230.3937
52 wk Range
183.1663-249.9
Market Cap
33 727 M
Dividends (Yield)
0.0079
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get RESMED data using free add-ons & libraries
Get RESMED Fundamental Data
RESMED Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
RESMED News
New
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
Resmed, Inc. SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer...
ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company
Key Insights Institutions' substantial holdings in ResMed implies that they have significant influence over the company's share price 50% of the business is held by the top 25 shareholders Using data...
Here's Why ResMed (RMD) is a Strong Growth Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made ea...
Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at patient monitoring stocks, starting wit...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
